BRIEF published on 09/12/2024 at 14:25, 2 months 8 days ago Amundi Asset Management reduces its stake in Arkema Voting Rights Participation Amundi Threshold Crossing ARKEMA
BRIEF published on 09/12/2024 at 09:53, 2 months 9 days ago Arkema announces a new capital increase for its employees Investment Capital Increase Subscription Employees ARKEMA
PRESS RELEASE published on 09/12/2024 at 09:48, 2 months 9 days ago Inside Information / Other news releases Arkema launches ninth capital increase for current and former employees in 31 countries. Subscription period: 16-30 September 2024. Price: €60.74/share. Total nominal value: €13.5 million Capital Increase Share Price Employees Subscription Period ARKEMA
BRIEF published on 09/06/2024 at 13:12, 2 months 15 days ago ARKEMA Reports Share and Voting Rights Count Voting Rights Shares Financial Disclosure Regulated Information ARKEMA
PRESS RELEASE published on 09/06/2024 at 13:07, 2 months 15 days ago Inside Information / Other news releases Press release regarding the statement on the number of shares and voting rights as per French commercial code and AMF regulations Voting Rights French Commercial Code Shares AMF Regulated Information
BRIEF published on 09/05/2024 at 19:05, 2 months 15 days ago Arkema Successfully Completes €500 Million Bond Issue Debt Management Bond Issue ARKEMA Financing Policy Materials Science
PRESS RELEASE published on 09/05/2024 at 19:00, 2 months 15 days ago Inside Information / Other news releases Arkema successfully completed a €500 million senior bond issue with 3.50% annual coupon to extend debt maturity, enhancing financing policy Debt Maturity Bond Issue ARKEMA Financing Policy Materials Science
BRIEF published on 09/03/2024 at 14:25, 2 months 17 days ago Arkema Discloses Recent Share Buyback Transactions Transactions Share Buyback Regulations Market ARKEMA
PRESS RELEASE published on 09/03/2024 at 14:20, 2 months 17 days ago Inside Information / Other news releases Arkema discloses trading in own shares from 26 to 28 August 2024, in line with regulations. Total volume acquired: 6,078 shares. More details on Arkema's website Shares Trading Buyback Regulations ARKEMA
BRIEF published on 08/27/2024 at 11:53, 2 months 25 days ago Arkema Announces Share Buyback Transactions Share Buyback Trading Financial Disclosure ARKEMA August 2024
Published on 11/21/2024 at 13:00, 28 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 28 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 28 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 13:00, 28 minutes ago Nextech3D.ai Spin-Out Rebrands as FOTOgpt.ai to Usher in a New Era of AI-Powered Photography
Published on 11/21/2024 at 13:00, 28 minutes ago Clean Air Metals Announces Positive Results from Innovative Seismic Survey at the Escape Deposit Down-Plunge Extension
Published on 11/21/2024 at 12:35, 53 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 13 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 6 hours 30 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 8 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 19 hours 43 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 19 hours 43 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 5 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
